Kent is a Senior Vice President of Strategy and leads Merkle’s Global Health Strategy practice. He has been consulting in the areas of pharmaceutical, provider, and payer strategy for more than 20 years. In addition to broad blog/whitepaper and conference activity, he is published extensively in a variety of journals including, Research in Social and Administrative Pharmacy, Formulary, the Journal of Clinical Pharmacy and Therapeutics, and the Journal of Database Marketing.
Kent has worked with a number of clients in the pharmaceutical, healthcare, and animal health vertical including AbbVie, AstraZeneca, BMS, Boehringer Ingelheim, Novartis, Sanofi (Genzyme, Chattem and Merial), OHSU, Emblem Health, and Anthem, focusing on engagement, communication, and CRM strategy in the US, Canada, Europe, and Australasia. He has a Ph.D. in pharmaceutical strategy and policy from Dalhousie University in Halifax, NS, and holds the position of Assistant Professor, Clinical Pharmacy, at the James L. Winkle College of Pharmacy, University of Cincinnati.
Kent's Articles, Blog Posts, Webinars and More
What Does the Future Hold for Peer Reviewed Medicine?
How Would You Rate Your Communications to HCPs?
CVS Health and Aetna will Redefine the Healthcare Experience for Consumers
Have You Thought About the Pharma Rep as the Orchestrator of the HCP Relationship?
The New Role of the Pharma Rep and Raising the Digital Stakes
